Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats
2005
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
The liver in celiac disease
2007
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
2011 Standout
Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study
2012
Monocyte activation in alcoholic liver disease
2002
Crohn's disease: monitoring disease activity
2003
Intestinal barrier: An interface between health and disease
2003
Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion Selectivity
2010
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
The biological action of saponins in animal systems: a review
2002 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Review article: the role of butyrate on colonic function
2007 Standout
Microbial tryptophan catabolites in health and disease
2018 Standout
Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis
2005
Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non-Small-Cell Lung Cancer
2004
Adherent-Invasive Escherichia coli Induce Claudin-2 Expression and Barrier Defect in CEABAC10 Mice and Crohnʼs Disease Patients§
2011
Twin studies in autoimmune disease: Genetics, gender and environment
2011
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation
2009
Intestinal Permeation and Gastrointestinal Disease
2002
The Gut Barrier
2012
Crohn's disease
2012 Standout
Predicting relapse in Crohn’s disease: a biopsychosocial model
2008
The Oslo definitions for coeliac disease and related terms
2012 Standout
A porous defense: the leaky epithelial barrier in intestinal disease
2004
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease
2006
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
2011
Five Years of GWAS Discovery
2012 Standout
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
2014 Standout
Epidemiology and risk factors for IBD
2015 Standout
Inflammatory Bowel Disease
2009 Standout
Loss of the Tight Junction Protein ZO-1 in Dextran Sulfate Sodium Induced Colitis
2007
Intestinal permeability in patients with adverse reactions to food
2006
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Celiac Disease
2007 Standout
Irritable bowel syndrome
2016 Standout
Mitochondrial dysfunction in cholestatic liver diseases
2011
Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease
2006 Standout
Intestinal barrier function: Molecular regulation and disease pathogenesis
2009
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells
2005
Intestinal mucosal barrier function in health and disease
2009 Standout
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
2017
Intestinal Permeability Defects: Is It Time to Treat?
2013
Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation
2016
The role of protein digestibility and antacids on food allergy outcomes
2008
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Low specificity of anti‐tissue transglutaminase antibodies in patients with primary biliary cirrhosis
2006
Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
2016
Influence of diet on the gut microbiome and implications for human health
2017 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Intestinal Permeability in Irritable Bowel Syndrome Patients: Effects of NSAIDs
2009
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease
2011 Standout
Helicobacter pyloriInfection
2002 Standout
Clinical Pharmacokinetics of Interferons
1990
Targeted Epithelial Tight Junction Dysfunction Causes Immune Activation and Contributes to Development of Experimental Colitis
2008
Ulcerative colitis
2020 Standout
Giardia and Cryptosporidium join the ‘Neglected Diseases Initiative’
2006 Standout
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease
2002
Macrophage M1/M2 polarization
2020 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Lactulose/Mannitol Test and Specificity, Sensitivity, and Area under Curve of Intestinal Permeability Parameters in Patients with Liver Cirrhosis and Crohn's Disease
2008
ABSENCE OF FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α ENHANCED ILEUM PERMEABILITY DURING EXPERIMENTAL COLITIS
2007
Autoantibodies to Gastric Mucosa in Helicobacter pylori Infection
1997
Systematic review: the evidence base for long‐term management of coeliac disease
2008
Celiac Disease and Autoimmune Thyroid Disease
2007
Influence ofSaccharomyces boulardiion the intestinal permeability of patients with Crohn's disease in remission
2008
Management of Crohn's Disease in Adults
2009 Standout
Verbascoside — A review of its occurrence, (bio)synthesis and pharmacological significance
2014 Standout
+49A/G polymorphism of cytotoxic T‐lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta‐analysis
2011
Molecular Basis of Epithelial Barrier Regulation
2006
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
Tight junctions and IBS ‐ the link between epithelial permeability, low‐grade inflammation, and symptom generation?
2014
Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy
2007
Gut flora and bacterial translocation in chronic liver disease
2006
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
PPAR-α
2010
Gene Signature–Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn’s Disease
2018
Microbial Translocation in Chronic Liver Diseases
2012
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation
2011
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Workshop Report: Prevention of Postoperative Recurrence in Crohn's Disease
2005
IL-2–Controlled Expression of Multiple T Cell Trafficking Genes and Th2 Cytokines in the Regulatory T Cell-Deficient Scurfy Mice: Implication to Multiorgan Inflammation and Control of Skin and Lung Inflammation
2010
Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
2014 Standout
Immune Interventions in Disease
1987
Cardiotoxicity of Cancer Therapy
2005
Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature
2013
Role of CD8 + and CD4 + T Lymphocytes in Jejunal Mucosal Injury during Murine Giardiasis
2004
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
2015
Epithelial Barriers in Homeostasis and Disease
2010
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
2017 StandoutNobel
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of C. Venturi being referenced
Gastric cell c-AMP stimulating autoantibodies in duodenal ulcer disease.
1988
Cytotoxic T-Lymphocyte–Associated Antigen-4 Single Nucleotide Polymorphisms and Haplotypes in Primary Biliary Cirrhosis
2007
Functional and morphological changes in small bowel of crohn's disease patients
1995
Gastroduodenal and intestinal permeability in primary biliary cirrhosis
2003
Intestinal Permeability Test As A Predictor of Clinical Course in Crohn's Disease
1999
HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: A large-scale study
2006
Dynamics of Allograft Fibrosis in Pediatric Liver Transplantation
2014
Lack of Higher Frequency of the Chemokine Receptor 5-??32/??32 Genotype in Hepatitis C
2006
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer
2002
Lactulose/Mannitol Test Has High Efficacy for Excluding Organic Causes of Chronic Diarrhea
2003
Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy
2002
Relationship between apoptasis, tumour necrosis factor, cell proliferation in chronic cholestasis
2001
High IgE serum levels and "peptic" ulcers: clinical and functional approach.
1994
[Raised levels of IgE and allergic diseases in patients subjected to esophagogastroduodenoscopy].
1989
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
1985
[Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
1994
Phase I study of recombinant beta-interferon given by four-hour infusion.
1987